Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Max Relief Full Spectrum CBD Gummies
- Development stage
- Unknown
- Lead developer
- Medterra
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Max Relief Full Spectrum CBD Gummies are a consumer wellness product developed by Medterra. These oral gummies contain a blend of 25mg of hemp-derived cannabidiol (CBD), 2mg of tetrahydrocannabinol (THC), and 3mg of minor cannabinoids including cannabinol (CBN), cannabigerol (CBG), cannabidiolic acid (CBDa), cannabidivarin (CBDV), and cannabichromene (CBC). The product is designed to interact with the body's endocannabinoid system to provide relief from physical discomfort and promote overall well-being. As a full-spectrum hemp extract product, it utilizes the "entourage effect," where multiple cannabinoids work synergistically to enhance therapeutic outcomes. It is marketed as a vegan and gluten-free supplement intended for daily use to manage discomfort and support a balanced lifestyle.
- Brand names
- Max Relief Full Spectrum CBD Gummies
- Other names
- Max Relief CBD Gummies
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Max Relief Full Spectrum CBD Gummies.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Max Relief Full Spectrum CBD Gummies.